Skip to main content
Intermediate Technical IVT

Reproductive Aging Panel

A hormone test panel designed to assess ovarian reserve and reproductive potential in aging women.

Full Definition

A reproductive aging panel is a comprehensive hormone assessment used to evaluate ovarian function and fertility potential as women approach reproductive senescence. The panel typically includes AMH as the primary ovarian reserve marker, along with cycle day 3 FSH, LH, and estradiol to assess baseline reproductive hormone status. Some panels may include inhibin B and antral follicle counts from ultrasound. The testing helps predict menopausal timing, assess fertility treatment success likelihood, and guide family planning decisions. Results must be interpreted in context of patient age, menstrual cycle regularity, and reproductive goals. The panel is particularly valuable for women over 35 considering pregnancy or those experiencing irregular cycles suggestive of declining ovarian function.

Usage

Usage note: Focus on ovarian reserve rather than general fertility when describing this panel.

In Context

  • "The reproductive aging panel showed declining ovarian reserve consistent with the patient's age and irregular cycles." — Reproductive endocrinology report
  • "Insurance coverage for the reproductive aging panel varies depending on patient age and clinical indication." — Prior authorization documentation

Also known as

ovarian reserve testing fertility aging assessment

Contrasted with

fertility optimization panel reproductive potential testing

Don't confuse with

perimenopause testing infertility workup

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON